Kathera Bioscience
Union
About Kathera Bioscience
Kathera Bioscience is developing therapies to treat fungal infections that are a major cause of human disease due to rising numbers of infections globally. KatheraBio aims to develop novel, broad-spectrum drugs to overcome the limitations of current treatment options.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $150.0K
- Last round: Grant (Aug 2022)
- Website: katherabio.com
- Phone: + 1 800 800 8000
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/kathera-bioscience-171313 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.